Koelbing, Claudia
Novartis (Switzerland) · Novartis Institutes for BioMedical Research
2 papers on CoChat
Most cited papers
- Verified
An Antibody Blocking Activin Type II Receptors Induces Strong Skeletal Muscle Hypertrophy and Protects from Atrophy
Lach-Trifilieff, E., Minetti, G. C., Sheppard, K., Ibebunjo, C., Feige, J. N., Hartmann, S., Brachat, S., Rivet, H., Koelbing, C., Morvan, F., et al. (2014) · Molecular and Cellular Biology
Muscle Physiology and DisordersTGF-β signaling in diseases
Cited by 306
- Verified
Blockade of activin type II receptors with a dual anti-ActRIIA/IIB antibody is critical to promote maximal skeletal muscle hypertrophy
Morvan, F., Rondeau, J.-M., Zou, C., Minetti, G., Scheufler, C., Scharenberg, M., Jacobi, C., Brebbia, P., Ritter, V., Toussaint, G., et al. (2017) · Proceedings of the National Academy of Sciences
Muscle Physiology and DisordersTGF-β signaling in diseases
Cited by 142
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free